The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $42.04

Today's change0.00 0.00%
Updated December 17 4:03 PM EST. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $42.04

Today's change0.00 0.00%
Updated December 17 4:03 PM EST. Delayed by at least 15 minutes.

GlaxoSmithKline PLC closed at (U.S.)$42.04.

Over the last five days, shares have lost 3.33% and sit 1.82% above their 52-week low. This security has underperformed the S&P 500 by 30.67% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $42.04
  • High--
  • Low--
  • Bid / Ask(U.S.) $42.00 / (U.S.) $42.05
  • YTD % change-21.26%
  • Volume9,857
  • Average volume (10-day)5,655,032
  • Average volume (1-month)3,985,384
  • Average volume (3-month)5,128,275
  • 52-week range(U.S.) $41.29 to (U.S.) $56.73
  • Beta0.69
  • Trailing P/E15.56×
  • P/E 1 year forward13.91×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.65
  • Dividend yield6.31%
  • Trailing EPS(U.S.) $2.70
Updated December 17 4:03 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.17%

Based on its net profit margin of 18.17%, GlaxoSmithKline PLC is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue5,6465,5615,6136,906
Total other revenue--------
Total revenue5,6465,5615,6136,906
Gross profit3,8943,8883,9084,773
Total cost of revenue1,7521,6731,7052,133
Total operating expense4,9434,4244,5474,212
Selling / general / administrative1,7951,9691,9192,094
Research & development742766784905
Depreciation / amortization17172323
Interest expense (income), net operating--------
Unusual expense (income)73871186-845
Other operating expenses, total-101-72-70-98
Operating income7031,1371,0662,694
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5489869032,546
Income after tax3857027192,505
Income tax, total16328418441
Net income4016546682,461
Total adjustments to net income--------
Net income before extra. items4016546682,461
Minority interest16-48-51-44
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4016546682,461
Inc. avail. to common incl. extra. items4016546682,461
Diluted net income4016546682,461
Dilution adjustment------0
Diluted weighted average shares4,8654,8744,8664,881
Diluted EPS excluding extraordinary itemsvalue per share0.080.130.140.50
Dividends per sharevalue per share0.190.190.190.23
Diluted normalized EPSvalue per share0.210.160.170.25